Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Alpha IVF earnings are projected to grow 18.9% in FY26, 20% in FY27 and 14.7% in FY28, supported by new centres, rising Chinese patient demand and a rebound in Singapore operations.
